Ultragenyx Pharmaceutical Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4165
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,150見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥48,300見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥72,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage bio-pharmaceutical company. The company classifies its business in a single business: the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases. It develops KRN23 (UX023) for the treatment of X-linked hypophosphatemia (XLH, a rare genetic disease that impairs bone growth); and tumor-induced osteomalacia It mainly operates in the US. The company also has a partnership with Takeda Pharmaceutical Company Limited to develop and commercialize therapies to treat rare genetic diseases. Ultragenyx is headquartered in Novato, California, the US.

Scope

- Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on Ultragenyx Pharmaceutical Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ultragenyx Pharmaceutical Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ultragenyx Pharmaceutical Inc.: Company Overview
Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
Ultragenyx Pharmaceutical Inc.: Overview
Ultragenyx Pharmaceutical Inc.: Key Facts
Ultragenyx Pharmaceutical Inc.: Key Employees
Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
Ultragenyx Pharmaceutical Inc.: Major Products and Services
Ultragenyx Pharmaceutical Inc.: Company History
Ultragenyx Pharmaceutical Inc.: Management Statement
Ultragenyx Pharmaceutical Inc.: Key Competitors
Ultragenyx Pharmaceutical Inc.: Company Analysis
Ultragenyx Pharmaceutical Inc.: Business Description
Ultragenyx Pharmaceutical Inc.: SWOT Analysis
Ultragenyx Pharmaceutical Inc.: SWOT Overview
Ultragenyx Pharmaceutical Inc.: Strengths
Ultragenyx Pharmaceutical Inc.: Weaknesses
Ultragenyx Pharmaceutical Inc.: Opportunities
Ultragenyx Pharmaceutical Inc.: Threats
Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
Ultragenyx Pharmaceutical Inc.: Targets and Partners
Ultragenyx Pharmaceutical Inc.: Top Deals 2016 – 2020YTD*
Ultragenyx Pharmaceutical Inc.: Advisors
Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions
Ultragenyx Pharmaceutical Inc.: Capital Raising
Ultragenyx Pharmaceutical Inc.: Partnership
Ultragenyx Pharmaceutical Inc.: Divestments
Ultragenyx Pharmaceutical Inc.: Recent Developments
Ultragenyx Pharmaceutical Inc.: News and Events Summary
Ultragenyx Pharmaceutical Inc.: Corporate Governance
Ultragenyx Pharmaceutical Inc.: Financial Performance
Ultragenyx Pharmaceutical Inc.: Market Developments
Ultragenyx Pharmaceutical Inc.: Research & Development
Ultragenyx Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
Table 3: Ultragenyx Pharmaceutical Inc.: Company History
Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors
Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Ultragenyx Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Ultragenyx Pharmaceutical Inc.: Targets and Partners
Table 9: Ultragenyx Pharmaceutical Inc.: Top Deals 2016 - 2020YTD*
Table 10: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Ultragenyx Pharmaceutical Inc.: News and Events Summary
Table 20: Ultragenyx Pharmaceutical Inc.: Corporate Governance
Table 21: Ultragenyx Pharmaceutical Inc.: Financial Performance
Table 22: Ultragenyx Pharmaceutical Inc.: Market Developments
Table 23: Ultragenyx Pharmaceutical Inc.: Research & Development
Table 24: Ultragenyx Pharmaceutical Inc.: Strategy and Operations

★海外企業調査レポート[Ultragenyx Pharmaceutical Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • E.ON SE (EOAN):石油・ガス:M&Aディール及び事業提携情報
    Summary E.ON SE(E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports and supplies gas, and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, nat …
  • Brookfield Asset Management Inc.:企業の戦略・SWOT・財務情報
    Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …
  • GSI Technology, Inc. (GSIT):企業の財務・戦略的SWOT分析
    GSI Technology, Inc. (GSIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Apple Inc:企業のM&A・事業提携・投資動向
    Apple Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apple Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Manchester United Plc:企業の戦略・SWOT・財務分析
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Coty Inc.:企業の戦略・SWOT・財務分析
    Coty Inc. - Strategy, SWOT and Corporate Finance Report Summary Coty Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • YTL Power International Bhd (YTLPOWR)
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • The Abraaj Group-エネルギー分野:企業M&A・提携分析
    Summary The Abraaj Group (Abraaj) is a financial service provider that offers private equity, investment and credit strategies for real estate operations. The company helps companies in their operational improvements, management incentives, optimization of capital structure and the use of leverage. …
  • Lydall Inc (LDL):企業の財務・戦略的SWOT分析
    Lydall Inc (LDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Energizer Holdings, Inc. (ENR):企業の財務・戦略的SWOT分析
    Energizer Holdings, Inc. (ENR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • First Philippine Holdings Corp (FPH):企業の財務・戦略的SWOT分析
    First Philippine Holdings Corp (FPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Veracyte Inc (VCYT):医療機器:M&Aディール及び事業提携情報
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • University of Louisville-製薬・医療分野:企業M&A・提携分析
    Summary University of Louisville (UofL) is an educational university that offers undergraduate, graduate, post-baccalaureate pre-med program, dentistry, law and online programs. The university offers courses such as accountancy, aerospace studies, art education, bioengineering, business administrati …
  • Hrvatska Elektroprivreda dd:企業の戦略的SWOT分析
    Hrvatska Elektroprivreda dd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SolarWinds North America Inc:企業の戦略的SWOT分析
    SolarWinds North America Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Origin Energy Ltd (ORG)-エネルギー分野:企業M&A・提携分析
    Summary Origin Energy Limited (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water s …
  • Align Technology, Inc. (ALGN)-医療機器分野:企業M&A・提携分析
    Summary Align Technology, Inc. (Align) is a medical device company that designs, manufactures and markets orthodontics and services for orthodontic and restorative dentistry. The company’s portfolio encompasses a system of clear aligner therapy, intra-oral scanners, and computer-aided design, and co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆